Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can persistently progress into a deadly condition even after clinical resolution of the acute ...

Accurate and rapid diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been instrumental in mitigating viral spread during the coronavirus disease 2019 (COVID-19) ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The U.S. Food and Drug Administration has granted Cellex an emergency use authorization to market a ...

The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...

The Simplexa COVID-19/Flu A/B  & RSV Direct Kit is used for the detection and differentiation of infections with SARS-CoV-2, flu A/B, and respiratory syncytial viruses.

Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly ...

A new Imperial College London-led study provides the first empirical evidence for transmission of SARS-CoV-2 via people’s hands and frequently touched household surfaces. The research sheds new light ...

Among over 800 children exposed to maternal SARS-CoV-2 infection during pregnancy, 16.3% had a neurodevelopmental diagnosis ...